VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171,000 | -45.0% | 18,257 | +44.0% | 0.00% | – |
| Q2 2023 | $311,000 | +49.5% | 12,678 | +41.4% | 0.00% | – |
| Q1 2023 | $208,000 | -42.2% | 8,965 | -36.9% | 0.00% | – |
| Q4 2022 | $360,000 | +355.7% | 14,198 | +244.2% | 0.00% | – |
| Q3 2022 | $79,000 | -14.1% | 4,125 | +14.1% | 0.00% | – |
| Q2 2022 | $92,000 | -73.0% | 3,615 | -72.7% | 0.00% | – |
| Q1 2022 | $341,000 | -41.7% | 13,253 | -5.2% | 0.00% | – |
| Q4 2021 | $585,000 | +5218.2% | 13,978 | +5491.2% | 0.00% | – |
| Q3 2021 | $11,000 | -8.3% | 250 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -90.1% | 250 | -89.4% | 0.00% | – |
| Q1 2021 | $121,000 | +2925.0% | 2,368 | +1427.7% | 0.00% | – |
| Q4 2020 | $4,000 | -33.3% | 155 | -11.9% | 0.00% | – |
| Q3 2020 | $6,000 | -40.0% | 176 | -29.6% | 0.00% | – |
| Q2 2020 | $10,000 | +42.9% | 250 | +15.7% | 0.00% | – |
| Q1 2020 | $7,000 | +16.7% | 216 | -57.1% | 0.00% | – |
| Q4 2019 | $6,000 | – | 503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |